Search Results - "Wik, Elin"

Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis by Julku, Ulrika, Xiong, Mengfei, Wik, Elin, Roshanbin, Sahar, Sehlin, Dag, Syvänen, Stina

“…Treatment with amyloid-β (Aβ) targeting antibodies is a promising approach to remove Aβ brain pathology in Alzheimer's disease (AD) and possibly even slow down…”
Get full text

Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease by Gustavsson, Tobias, Metzendorf, Nicole G, Wik, Elin, Roshanbin, Sahar, Julku, Ulrika, Chourlia, Aikaterini, Nilsson, Per, Andersson, Ken G, Laudon, Hanna, Hultqvist, Greta, Syvänen, Stina, Sehlin, Dag

“…Brain-directed immunotherapy is a promising strategy to target amyloid-β (Aβ) deposits in Alzheimer's disease (AD). In the present study, we compared the…”
Get full text

Antibody engagement with amyloid-beta does not inhibit 11CPiB binding for PET imaging by Xiong, Mengfei, Dahlén, Amelia, Roshanbin, Sahar, Wik, Elin, Aguilar, Ximena, Eriksson, Jonas, Sehlin, Dag, Syvänen, Stina

“…The elimination of amyloid-beta (Aβ) plaques in Alzheimer's disease patients after treatment with anti-Aβ antibodies such as lecanemab and aducanumab is…”
Get full text

Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging by Xiong, Mengfei, Dahlén, Amelia, Roshanbin, Sahar, Wik, Elin, Aguilar, Ximena, Eriksson, Jonas, Sehlin, Dag, Syvänen, Stina

“…The elimination of amyloid‐beta (Aβ) plaques in Alzheimer's disease patients after treatment with anti‐Aβ antibodies such as lecanemab and aducanumab is…”
Get full text

Brain pharmacokinetics of mono- and bispecific amyloid-[beta] antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis by Julku, Ulrika, Xiong, Mengfei, Wik, Elin, Roshanbin, Sahar, Sehlin, Dag, Syvänen, Stina

“…Background Treatment with amyloid-[beta] (A[beta]) targeting antibodies is a promising approach to remove A[beta] brain pathology in Alzheimer's disease (AD)…”
Get full text

Long-term effects of immunotherapy with a brain penetrating A[beta] antibody in a mouse model of Alzheimer's disease by Gustavsson, Tobias, Metzendorf, Nicole G, Wik, Elin, Roshanbin, Sahar, Julku, Ulrika, Chourlia, Aikaterini, Nilsson, Per, Andersson, Ken G, Laudon, Hanna, Hultqvist, Greta, Syvänen, Stina, Sehlin, Dag

“…Background Brain-directed immunotherapy is a promising strategy to target amyloid-[beta] (A[beta]) deposits in Alzheimer's disease (AD). In the present study,…”
Get full text